Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
AI VIVO has announced its platform correctly identified dexamethasone as having high potential for the treatment of COVID-19 in April 2020.
read more
ArcherDX is entering into a collaboration with Bristol Myers to utilize PCM assays to understand the potential benefits of MRD detection in cancer patients treated with immunotherapy.
read more
Lyell Immunopharma and PACT Pharma have announced a strategic partnership to jointly develop and test a next generation personalized anti-cancer T cell therapy against solid tumors.
read more
Sirnaomics and PNI jointly announced a partnership on the development and manufacture of Sirnaomics polypeptide nanoparticle-based RNAi therapeutic product.
read more
Avacta Group announced collaborative work with the Centre for Virus Research at the University of Glasgow has shown that Affimer reagents which bind to the SARS-COV-2 virus spike protein prevent infection of human cells by a SARS-COV-2 model virus.
read more
Piramal has entered into an agreement with G&W Laboratories to acquire its solid oral dosage drug product manufacturing facility located in Sellersville, Pennsylvania.
read more
TTP plc has entered into a technology advisory partnership with Cancer Research UK.
read more
Catalyst Biosciences has announced the appointment of Charles Democko as Senior Vice President, Regulatory Affairs.
read more
Ajinomoto Bio-Pharma Services has announced the launch of AJILITY™, a flexible and agile drug product manufacturing platform.
read more
ImmunoPrecise and LiteVax announced a preclinical study to analyze IPA's novel SARS-CoV-2 vaccine candidates, has been granted funding by TRANSVAC2.
read more
Cambrex announced Tom Loewald has been named Chief Executive Officer and a member of the company’s Board of Directors, effective September 7th.
read more
Altasciences has announced the appointment of Dr. Joseph A. Francisco as Chief Toxicologist.
read more
Catalent has signed an agreement with ViralClear to work on the development of a potential treatment for adults with advanced COVID-19.
read more
FDA issued a guidance entitled, “Good Manufacturing Practice Considerations for Responding to COVID-19 Infection in Employees in Drug and Biological Manufacturing.”
read more
Sygnature Discovery has announced the appointment of Dr. Paul Overton as Senior VP of Business Development.
read more